Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With a new generation of fast and affordable gene sequencers, researchers are better equipped than ever to tackle Earth’s ...

Agriculture, from the outset, has been made possible by humans tweaking the genes of plants to make them grow faster, produce ...

Artificial intelligence is rapidly becoming medicine’s most powerful microscope, revealing patterns in human DNA that were ...

The cost of decoding our genetic makeup has plummeted. Just because it’s affordable doesn’t necessarily mean it’s worth doing ...

Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medical Oncology ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

A tiny percentage of our DNA—around 2%—contains 20,000-odd genes. The remaining 98%—long known as the non-coding genome, or ...

Researchers identify GRIN2A as a rare single-gene cause of early psychiatric disorders, with symptoms often beginning in ...

DNA captured on air filters and stored since the 1960s acts as an ecological time capsule, according to a recent publication ...